privacy

Pharmalot By Ed Silverman

Targeting prices for accelerated approval drugs may have limited impact on overall drug spending

Biotech By Matthew Herper

Acadia drug meets endpoints for treating Rett syndrome, a rare neurological disease

Politics By Nicholas Florko

As Biden touts his effort to cap insulin prices, advocates push for an even more ambitious reform

Health By Elizabeth Cooney

Salary gap between male and female physicians adds up to $2 million in lifetime earnings

Pharmalot By Ed Silverman

An advocacy group seeks to broaden access to a Pfizer Covid-19 pill

First Opinion By Tahir Amin and Priti Krishtel

Solving the U.S. drug pricing crisis starts with a crucial confirmation hearing

Pharmalot By Ed Silverman

Pharmalittle: Covid-19 pills may take longer to reach poor countries; J&J Covid booster may be as beneficial as a third Pfizer shot

First Opinion By Michael L. Millenson

It’s time to open up health care’s secret analytics